Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunner

Showing results (481-490 of 12,174) with videos related to

Pageof 1,218
Sort By:
Life Sciences|January 1, 1988
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and IIJ Nussberger, D B Brunner, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
True versus immunoreactive angiotensin II in human plasmaJ Nussberger, D B Brunner, B Waeber, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1984
Measurement of low angiotensin concentrations after ethanol and Dowex extraction proceduresJ Nussberger, D B Brunner, B Waeber, et al.
Developmental Biology|February 13, 1999
The dominant mutation Glazed is a gain-of-function allele of wingless that, similar to loss of APC, interferes with normal eye developmentE Brunner, D Brunner, W Fu, et al.
International Journal of Environmental Analytical Chemistry|January 1, 1986
Octapeptide-specific and sensitive assay for angiotensin II in plasmaJ Nussberger, D B Brunner, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1986
Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasmaJ Nussberger, D B Brunner, B Waeber, et al.
American Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R Brunner
Praxis|March 11, 1998
[Preventive medicine: costs and responsibilities of insurance companies]H H Brunner
British Medical Journal|May 31, 1980
Recurrent abdominal pain in childhoodP C Brunner
ZFA. Zeitschrift Fur Allgemeinmedizin|January 20, 1981
[Various viewpoints on varicose surgery 1980]U V Brunner
Pageof 1,218

Showing results (481-490 of 12,174) with videos related to

Sort By:
Pageof 1,218
Life Sciences|January 1, 1988
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and IIJ Nussberger, D B Brunner, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
True versus immunoreactive angiotensin II in human plasmaJ Nussberger, D B Brunner, B Waeber, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1984
Measurement of low angiotensin concentrations after ethanol and Dowex extraction proceduresJ Nussberger, D B Brunner, B Waeber, et al.
Developmental Biology|February 13, 1999
The dominant mutation Glazed is a gain-of-function allele of wingless that, similar to loss of APC, interferes with normal eye developmentE Brunner, D Brunner, W Fu, et al.
International Journal of Environmental Analytical Chemistry|January 1, 1986
Octapeptide-specific and sensitive assay for angiotensin II in plasmaJ Nussberger, D B Brunner, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1986
Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasmaJ Nussberger, D B Brunner, B Waeber, et al.
American Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R Brunner
Praxis|March 11, 1998
[Preventive medicine: costs and responsibilities of insurance companies]H H Brunner
British Medical Journal|May 31, 1980
Recurrent abdominal pain in childhoodP C Brunner
ZFA. Zeitschrift Fur Allgemeinmedizin|January 20, 1981
[Various viewpoints on varicose surgery 1980]U V Brunner
Pageof 1,218